🏥 治験ポータル
← 治験一覧に戻る

TACT-NAGOYA:細胞移植を用いた治療的血管新生

基本情報

NCT ID
NCT00145262
ステータス
不明
試験のフェーズ
-
試験タイプ
観察
目標被験者数
-
治験依頼者名
Nagoya University

概要

Clinical studies have established that implantation of bone marrow mononuclear cells (BM-MNCs) or peripheral blood mononuclear cells (PB-MNCs) into ischaemic limbs increases collateral vessel formation. We, the investigators at Nagoya University, further investigated the efficacy and safety of autologous implantation of BM-MNCs or PB-MNCs in patients with severe ischaemic limbs who have no other alternative therapeutic options. We also examined a potential limiting factor which reduced the efficacy of therapeutic angiogenesis using cell transplantation (TACT).

対象疾患

Buerger DiseaseArteriosclerosis Obliterans

介入

Autologous Bone Marrow Mononuclear Cell Implantation(PROCEDURE)

依頼者(Sponsor)

実施施設 (1)

すみクリニック 内科・循環器内科・小児科

Nagoya, Japan(RECRUITING)